Kaló Z - Search Results

1

Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook.

Callenbach MHE, Ádám L, Vreman RA, Németh B, Kaló Z, Goettsch WG. Callenbach MHE, et al. Among authors: kalo z. Drug Discov Today. 2023 Jan;28(1):103433. doi: 10.1016/j.drudis.2022.103433. Epub 2022 Nov 11. Drug Discov Today. 2023. PMID: 36372328 Free article.

2

Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation.

Keown P, Balshaw R, Khorasheh S, Chong M, Marra C, Kalo Z, Korn A. Keown P, et al. Among authors: kalo z. BioDrugs. 2003;17(4):271-9. doi: 10.2165/00063030-200317040-00006. BioDrugs. 2003. PMID: 12899644

3

Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments.

Redekop WK, Stolk EA, Kok E, Lovas K, Kalo Z, Busschbach JJ. Redekop WK, et al. Among authors: kalo z. Diabetes Metab. 2004 Dec;30(6):549-56. doi: 10.1016/s1262-3636(07)70154-4. Diabetes Metab. 2004. PMID: 15671925

4

Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation.

Radeva JI, Reed SD, Kaló Z, Kauf TL, Cantu E 3rd, Cretin N, Schulman KA. Radeva JI, et al. Among authors: kalo z. Clin Transplant. 2005 Feb;19(1):122-9. doi: 10.1111/j.1399-0012.2004.00312.x. Clin Transplant. 2005. PMID: 15659145 Clinical Trial.

5

The cost effectiveness of Apligraf treatment of diabetic foot ulcers.

Redekop WK, McDonnell J, Verboom P, Lovas K, Kalo Z. Redekop WK, et al. Among authors: kalo z. Pharmacoeconomics. 2003;21(16):1171-83. doi: 10.2165/00019053-200321160-00003. Pharmacoeconomics. 2003. PMID: 14594438

6

The expanded criteria donor dilemma in cadaveric renal transplantation.

Schnitzler MA, Whiting JF, Brennan DC, Lin G, Chapman W, Lowell J, Boxerman S, Hardinger KL, Kalo Z. Schnitzler MA, et al. Among authors: kalo z. Transplantation. 2003 Jun 27;75(12):1940-5. doi: 10.1097/01.TP.0000076381.16276.1B. Transplantation. 2003. PMID: 12829891

7

[Health prospects in the alternative strategies of renal replacement therapies].

Kaló Z, Járay J, Nagy J, Megyesi A, Hídvégi M. Kaló Z, et al. Orv Hetil. 2000 Aug 6;141(32):1761-5. Orv Hetil. 2000. PMID: 10979304 Hungarian.

8

[Decision analytic modeling and their impact on health care decision making].

Inotai A, Kaló Z, Mészáros A. Inotai A, et al. Among authors: kalo z. Acta Pharm Hung. 2009;79(2):63-9. Acta Pharm Hung. 2009. PMID: 19634636 Hungarian.

9

[Assessment of the pharmaceutical expenditure in Hungary].

Inotai A, Merész G, Kaló Z. Inotai A, et al. Among authors: kalo z. Acta Pharm Hung. 2010;80(4):162-72. Acta Pharm Hung. 2010. PMID: 21404477 Hungarian.

10

The life-years saved by a deceased organ donor.

Schnitzler MA, Whiting JF, Brennan DC, Lentine KL, Desai NM, Chapman W, Abbott KC, Kalo Z. Schnitzler MA, et al. Among authors: kalo z. Am J Transplant. 2005 Sep;5(9):2289-96. doi: 10.1111/j.1600-6143.2005.01021.x. Am J Transplant. 2005. PMID: 16095511 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page